Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Kidney problems news


From To
Analysis Backs New Tenofovir’s Kidney Safety Over Old Version

Researchers compared data on more than 9,000 people with HIV who took either version of tenofovir.

11 July 2019
Patients with HIV less likely to be waitlisted for kidney transplant

Patients with HIV were less likely to be placed on the kidney transplant waitlist than patients without HIV, according to research presented at the American Transplant Congress. They also experienced longer wait-times from evaluation to listing.

25 June 2019
World’s First HIV-To-HIV Kidney Transplant With Living Donor Succeeds

The world’s first kidney transplant from a living HIV-positive donor to another HIV-positive person was successfully performed Monday by doctors at a Johns Hopkins University hospital.

29 March 2019
Kaiser Health News
Atlanta woman becomes country's first HIV+ living kidney donor

If you ask Nina Martinez why she has fought so hard to become the first HIV + living kidney donor, her answer is pretty simple. "I just wanted to be just like anybody else," Martinez says. "I think, in 2019, this is going to blow a lot of peoples' minds. Because I'm sitting here today, as someone living for 35 years with HIV, and I'm about to donate this organ."

29 March 2019
FOX 5 Atlanta
On-Demand PrEP With TDF/FTC Not Associated With Clinically Relevant Decline in Kidney Function

On-demand pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) is not associated with a significant relevant in kidney function, especially among young people with low pill use and high baseline estimated glomerular filtration rate, investigators in France found.

20 March 2019
Contagion Live
Descovy is non-inferior to Truvada for daily PrEP

A daily pill containing the newer formulation of tenofovir in combination with emtricitabine (Descovy) had a comparable protective effect to the existing daily pill which contains the older

06 March 2019
Roger Pebody
Cocaine use associated with poor adherence to PrEP and dropping out of care

Cocaine users have poorer adherence to HIV pre-exposure prophylaxis (PrEP) and engagement with care, according to research published in the online edition of the Journal of Acquired

22 February 2019
Michael Carter
Tenofovir Alafenamide Linked to Fanconi Syndrome

This case study is presented as a caution to clinicians that tenofovir alafenamide can cause Franconi Syndrome.

12 February 2019
Infectious Disease Advisor
Smoking, cholesterol, blood pressure are more important causes of disease than HIV in people living with HIV

Preventing smoking, lowering cholesterol, controlling blood pressure and curing hepatitis C would greatly reduce the burden of heart attacks, non-AIDS cancers and end-stage liver disease and kidney

11 February 2019
Keith Alcorn
Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia

Among HIV-positive children with liver and kidney abnormalities, liver enzyme abnormalities improved while kidney function progressively deteriorated the longer the children were on antiretroviral therapy (ART). With the

02 January 2019
Carole Leach-Lemens
← First12345...15Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.